Study on Blood Pressure, e-GFR, Serum Albumin, C-reactive Protein in Normal Subjects and Patients with CKD

M M Huq1, A Nessa, F Rahman

  • 1Dr Mohammad Mozammal Huq, M Phil (Thesis Part), Department of Physiology, Mymensingh Medical College (MMC), Mymensingh, Bangladesh; E-mail: mozammal huq120@gmail.com.

PubMed

Insights

Chronic kidney disease (CKD) patients exhibit significantly lower estimated glomerular filtration rate (eGFR) and serum albumin levels. These patients also show increased blood pressure and C-reactive protein (CRP) levels compared to healthy individuals.

Area of Science:

  • Nephrology
  • Clinical Physiology
  • Biochemistry

Background:

  • Chronic kidney disease (CKD) is often asymptomatic in early stages, characterized by a gradual decline in kidney function.
  • Inflammation, indicated by elevated C-reactive protein (CRP) levels, is a common comorbidity in CKD, correlating with reduced estimated glomerular filtration rate (eGFR) and serum albumin.

Purpose of the Study:

  • To investigate and compare key physiological and biochemical markers between patients with chronic kidney disease and healthy subjects.
  • Specifically, to determine alterations in blood pressure, eGFR, serum albumin, and CRP levels in CKD patients.

Main Methods:

  • A cross-sectional analytical study involving 140 participants (70 CKD patients, 70 healthy controls), aged 25-70 years.
  • eGFR was calculated using the CKD-EPI equation. Blood pressure, serum albumin, and CRP levels were measured.
  • Data were analyzed using unpaired t-tests to compare groups, with results expressed as mean ± SD.

Main Results:

  • CKD patients demonstrated significantly lower eGFR and serum albumin levels compared to the control group.
  • Elevated systolic and diastolic blood pressure, along with significantly higher CRP levels, were observed in the CKD patient group.
  • Gender-specific data showed variations, with females in the CKD group exhibiting lower serum albumin and higher CRP than males.

Conclusions:

  • CKD is significantly associated with impaired kidney function (low eGFR), reduced nutritional status (low albumin), hypertension, and heightened inflammation (high CRP).
  • These findings underscore the importance of early CKD detection to mitigate progression and associated cardiovascular complications.
  • Monitoring these biomarkers is crucial for managing CKD patients and preventing end-stage renal disease.

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
9
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
28
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
21
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
2.9K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
114